Artiva Biotherapeutics, Inc.
SEC CIK 1817241 · ARTV · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| RA Capital Healthcare Fund LP | Director | filed 2024 - 2026 |
| RA Capital Management, LLC | Director | filed 2024 - 2026 |
| Kolchinsky Peter | Director | filed 2024 - 2026 |
| Shah Rajeev M. | Director | filed 2024 - 2026 |
| RA Capital Nexus Fund, L.P. | Director | filed 2024 - 2026 |
| RA Capital Nexus Fund III, L.P. | Director | filed 2024 - 2026 |
| Miralles Gines Diego | Director · President & Head of R&D | filed 2024 - 2026 |
| Aslan Fred | Director · President and CEO | filed 2024 - 2026 |
| Sorg Elaine K. | Director | filed 2026 - 2026 |
| Hougen Elizabeth L | Director | filed 2024 - 2025 |
| Daniels Brian | Director | filed 2024 - 2025 |
| Moore Alison | Director | filed 2024 - 2025 |
| Stoppel Laura | Director | filed 2024 - 2025 |
| Baker Daniel G. | Director | filed 2025 - 2025 |
| Huh Yong-Jun | Director | filed 2024 - 2024 |
| Bessen Laura | Director | filed 2024 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bush Jennifer | COO, CLO, Secy, Compliance Off | filed 2024 - 2026 |
| Horan Christopher | Chief Tech Operations Officer | filed 2024 - 2026 |
| Raymon Heather | SVP, Research and Development | filed 2024 - 2026 |
| Banerjee Subhashis | Chief Medical Officer | filed 2025 - 2026 |
| Huston Thad Allen | Chief Financial Officer | filed 2026 - 2026 |
| Krishnamohan Neha | Chief Financial Officer | filed 2024 - 2025 |
| Graef Thorsten | Chief Medical Officer | filed 2024 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.